MedPath

Clinical research of Siddha medicine ATHIMATHURA CHOORNAM in Treatment of OTTRAI THALAIVALI(MIGRAINE)

Phase 2
Not yet recruiting
Conditions
migraine(Oruthalai Avartham)
Registration Number
CTRI/2017/05/008657
Lead Sponsor
National institute of Siddha
Brief Summary

It is sigle arm AN OPEN CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA HERBAL FORMULATION   â€œATHIMATHURA  CHOORNAM†IN THE TREATMENT OF ORUTHALAI AVARTHAM( MIGRAINE ). In this trail 40 migraine patients will be recruited and the trail drug will be administered 2 gram twice a day along with water for a period of 30 days.During the trail period all the study related data will be recorded and documented in a separate trail master file for each patients.During the study period if any adverse effect will be noticed and referred to pharmacovigilance dept in NIS aand further management will also be given in NIS OPDIPD. the entire trail will be monitored by research monitoring committee of NIS. During this trail all the safety and efficacy parameters will be recorded in the CRF. After completion of the trail all the study related data will be analysed statistically. The outcome of this trail will be published in Indian journal of Medical Research.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

1.Patients with complaints of Headache more than 6 months duration (untreated or unsuccessfully treated) 2.Nature of headache-Unilateral and Pulsating quality Moderate or severe pain intensity 3.Aggravation by or causing avoidance of routine physical activity 4.Headache associated with Nausea and/or vomiting Photophobia or Phonophobia.

Exclusion Criteria

1.Pregnant and Lactating women 2.Patient with anti-psychiatric treatment 3.Chronic Alcoholic patients 4.Hypertension, 5.Diabetes mellitus 6.Any systemic disease 7.Past history of head injury 8.History of Sinusitis 9.History of any space occupying lesion in brain.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The outcome is mainly assessed by clinical symptom, scoring HIT- Headache Impact Test questionnaire.30 days
Reduction in the episode of headache, duration of headache, increase quality of life30 days
Secondary Outcome Measures
NameTimeMethod
Influence of other co factors related to the disease such as Age, Sex, zodiac sign & stars etc..Pre study screening and after treatment

Trial Locations

Locations (1)

Ayothidoss Pandithar Hospital

🇮🇳

Kancheepuram, TAMIL NADU, India

Ayothidoss Pandithar Hospital
🇮🇳Kancheepuram, TAMIL NADU, India
Dr N Govindaraj
Principal investigator
8489040896
ngrsiddha91@mail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.